SEARCH

SEARCH BY CITATION

References

  • Abramowicz, M. J., Dessars, B., Sevens, C., Goossens, M. & Boulandet, E. G. 2000. Fetal bowel hyperechogenicity may indicate mild atypical cystic fibrosis: a case associated with a complex CFTR allele. J Med Genet 37, E15.
  • Akabas, M. H. 2000. Cystic fibrosis transmembrane conductance regulator. Structure and function of an epithelial chloride channel [In Process Citation]. J Biol Chem 275, 372932.
  • Anand, R., Ogilvie, D. J., R. Butler, Riley, J. H., Finniear, R. S., Powell, S. J., Smith, J. C. & Markham, A. F. 1991. A yeast artificial chromosome contig encompassing the cystic fibrosis locus. Genomics 9, 12430.
  • Arkwright, P. D., Laurie, S., Super, M., Pravica, V., Schwarz, M. J., Webb, A. K. & Hutchinson, I. V. 2000. TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax 55, 45962.
  • Audrezet, M. P., Chen, J. M., Le Marechal, C., Ruszniewski, P., Robaszkiewicz, M., Raguenes, O., Quere, I., Scotet, V. & Ferec, C. 2002. Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis. Eur J Hum Genet 10, 1006.
  • Borgo, G., Cabrini, G., Mastella, G., Ronchetto, P., Devoto, M. & Romeo, G. 1993. Phenotypic intrafamilial heterogeneity in cystic fibrosis. Clin Genet 44, 489.
  • Bronsveld, I., Mekus, F., Bijman, J., Ballmann, M., De Jonge, H. R., Laabs, U., Halley, D. J., Ellemunter, H., Mastella, G., Thomas, S., Veeze, H. J. & Tummler, B. 2001. Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings. J Clin Invest 108, 170515.
  • Buratti, E., Dork, T., Zuccato, E., Pagani, F., Romano, M. & Baralle, F. E. 2001. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. Embo J 20, 177484.
  • Cartegni, L., Chew, S. L. & Krainer, A. R..2002. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3, 28598.
  • Casals, T., Ramos, M. D., Gimenez, J., Larriba, S., Nunes, V. & Estivill, X. 1997. High heterogeneity for cystic fibrosis in Spanish families: 75 mutations account for 90% of chromosomes. Hum Genet 101, 36570.
  • Cheng, S. H., Gregory, R. J., Marshall, J., Paul, S., Souza, D. W., White, G. A., O'Riordan, C. R. & Smith, A. E. 1990. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63, 82734.
  • Chiba-Falek, O., Kerem, E., Shoshani, T., Aviram, M., Augarten, A., Bentur, L., Tal, A., Tullis, E., Rahat, A. & Kerem, B. 1998. The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C [RIGHTWARDS ARROW] T mutation. Genomics 53, 27683.
  • Choi, J. Y., Muallem, D., Kiselyov, K., Lee, M. G., Thomas, P. J. & Muallem, S. 2001. Aberrant CFTR-dependent HCO3-transport in mutations associated with cystic fibrosis. Nature 410, 947.
  • Chu, C. S., Trapnell, B. C., Curristin, S., Cutting, G. R. & Crystal, R. G. 1993. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet 3, 1516.
  • Chu, C. S., Trapnell, B. C., Murtagh, J. J., Moss, J. Jr., Dalemans, W. Jallat, S., Mercenier, A., Pavirani, A., Lecocq, J. P., Cutting, G. R. & et al 1991. Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium. Embo J 10, 135563.
  • Clain, J., Fritsch, J., Lehmann-Che, J., Bali, M., Arous, N., Goossens, M., Edelman, A. & Fanen, P. 2001. Two mild cystic fibrosis-associated mutations result in severe cystic fibrosis when combined in cis and reveal a residue important for cystic fibrosis transmembrane conductance regulator processing and function. J Biol Chem 276, 90459.
  • Clancy, J. P., Bebok, Z., Ruiz, F., King, C., Jones, J., Walker, L., Greer, H., Hong, J., Wing, L., Macaluso, M., Lyrene, R., Sorscher, E. J. & Bedwell, D. M. 2001. Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis. Am J Respir Crit Care Med 163, 168392.
  • Cohn, J. A., Friedman, K. J., Noone, P. G., Knowles, M. R., Silverman, L. M. & Jowell, P. S. 1998. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 339, 6538.
  • Cuppens, H., Lin, W., Jaspers, M., Costes, B., Teng, H., Vankeerberghen, A., Jorissen, M., Droogmans, G., Reynaert, I., Goossens, M., Nilius, B. & Cassiman, J. J. 1998. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest 101, 48796.
  • Cystic Fibrosis Genetic Analysis Consortium 1994. Population variation of common cystic fibrosis mutations. Hum Mut 16777
  • De Braekeleer, M., Allard, C., Leblanc, J. P., Simard, F. & Aubin, G. 1997. Genotype-phenotype correlation in cystic fibrosis patients compound heterozygous for the A455E mutation. Hum Genet 101, 20811.
  • Dork, T., Wulbrand, U., Richter, T., Neumann, T., Wolfes, H., Wulf, B., Maass, G. & Tummler, B. 1991. Cystic fibrosis with three mutations in the cystic fibrosis transmembrane conductance regulator gene. Hum Genet 87, 4416.
  • Drumm, M. 2001. Modifier genes and variation in cystic fibrosis. Respir Res 2, 125128.
  • Ellsworth, R. E., Jamison, D. C., Touchman, J. W., Chissoe, S. L., Braden Maduro, V. V., Bouffard, G. G., Dietrich, N. L., Beckstrom-Sternberg, S. M., Iyer, L. M., Weintraub, L. A., Cotton, M., Courtney, L., Edwards, J., Maupin, R., Ozersky, P., Rohlfing, T., Wohldmann, P., Miner, T., Kemp, K., Kramer, J., Korf, I., Pepin, K., Antonacci-Fulton, L., Fulton, R. S., Green, D. & et al 2000. Comparative genomic sequence analysis of the human and mouse cystic fibrosis transmembrane conductance regulator genes. Proc Natl Acad Sci U S A 97, 11727.
  • Estivill, X., Ortigosa, L., Perez-Frias, J., Dapena, J., Ferrer, J., Pena, L., Llevadot, R., Gimenez, J., Nunes, V. & et al 1995. Clinical characteristics of 16 cystic fibrosis patients with the missense mutation R334W, a pancreatic insufficiency mutation with variable age of onset and interfamilial clinical differences. Hum Genet 95, 3316.
  • Gabriel, S. E., Brigman, K. N., Koller, B. H., Boucher, R. C. & Stutts, M. J. 1994. Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science 266, 1079.
  • Garred, P., Pressler, T., Madsen, H. O., Frederiksen, B., Svejgaard, A., Hoiby, N., Schwartz, M. & Koch, C. 1999. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 104, 4317.
  • Girodon, E., Cazeneuve, C., Lebargy, F., Chinet, T., Costes, B., Ghanem, N., Martin, J., Lemay, S., Scheid, P., Housset, B., Bignon, J. & Goossens, M. 1997. CFTR gene mutations in adults with disseminated bronchiectasis. Eur J Hum Genet 5, 14955.
  • Green, E. D. & Olson, M. V. 1990. Chromosomal region of the cystic fibrosis gene in yeast artificial chromosomes: a model for human genome mapping. Science 250, 948.
  • Haardt, M., Benharouga, M., Lechardeur, D., Kartner, N. & Lukacs, G. L. 1999. C-terminal truncations destabilize the cystic fibrosis transmembrane conductance regulator without impairing its biogenesis. A novel class of mutation. J Biol Chem 274, 218737.
  • Hefferon, T. W., Broackes-Carter, F. C., Harris, A. & Cutting, G. R. 2002. Atypical 5' Splice Sites Cause CFTR Exon 9 To Be Vulnerable to Skipping. Am J Hum Genet 71, 294303.
  • Henry, M. T., Cave, S., Rendall, J., O'Connor, C. M., Morgan, K., FitzGerald, M. X. & Kalsheker, N. 2001. An alpha1-antitrypsin enhancer polymorphism is a genetic modifier of pulmonary outcome in cystic fibrosis. Eur J Hum Genet 9, 2738.
  • Hentze, M. W. & Kulozik, A. E. 1999. A perfect message: RNA surveillance and nonsense-mediated decay. Cell 96, 30710.
  • Higgins, C. F. 1992. ABC transporters: from microorganisms to man. Annu Rev Cell Biol 8, 67113.
  • Highsmith, W. E., Burch, L. H., Zhou, Z., Olsen, J. C., Boat, T. E., Spock, A., Gorvoy, J. D., Quittel, L., Friedman, K. J., Silverman, L. M. & et al 1994 A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med 331, 97480.
  • Hogenauer, C., Santa Ana, C. A., Porter, J. L., Millard, M., Gelfand, A., Rosenblatt, R. L., Prestidge, C. B. & Fordtran, J. S. 2000. Active intestinal chloride secretion in human carriers of cystic fibrosis mutations: an evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion. Am J Hum Genet 67, 14227.
  • Howard, M., Frizzell, R. A. & Bedwell, D. M. 1996. Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations. Nat Med 2, 4679.
  • Hull, J., Shackleton, S. & Harris, A. 1993. Abnormal mRNA splicing resulting from three different mutations in the CFTR gene. Hum Mol Genet 2, 68992.
  • Hull, J. & Thomson, A. H. 1998. Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis. Thorax 53, 101821.
  • Hung, L. W., Wang, I. X., Nikaido, K., Liu, P. Q., Ames, G. F. & Kim, S. H. 1998. Crystal structure of the ATP-binding subunit of an ABC transporter [see comments]. Nature 396, 7037.
  • Kalin, N., Claass, A., Sommer, M., Puchelle, E. & Tummler, B. 1999. DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis. J Clin Invest 103, 137989.
  • Kartner, N., Augustinas, O., Jensen, T. J., Naismith, A. L. & Riordan, J. R. 1992. Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland. Nat Genet 1, 3217.
  • Kerem, B., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, K., Chakravarti, A., Buchwald, M. & Tsui, L.C. 1989. Identification of the cystic fibrosis gene: genetic analysis. Science 245, 107380.
  • Kiesewetter, S., Macek, M., Davis, C. Jr, Curristin, S. M., Chu, C. S., Graham, C., Shrimpton, A. E., Cashman, S. M., Tsui, L. C., Mickle, J. & et al. 1993. A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat Genet 5, 2748.
  • Lazaro, C., De Cid, R., Sunyer, J., Soriano, J., Gimenez, J., Alvarez, M., Casals, T., Anto, J. M. & Estivill, X. 1999. Missense mutations in the cystic fibrosis gene in adult patients with asthma. Hum Mutat 14, 5109.
  • Mahadeva, R., Westerbeek, R. C., Perry, D. J., Lovegrove, J. U., Whitehouse, D. B., Carroll, N. R., Ross-Russell, R. I, Webb, A. K., Bilton, D. & Lomas, D. A. 1998. Alpha1-antitrypsin deficiency alleles and the Taq-I G [RIGHTWARDS ARROW] A allele in cystic fibrosis lung disease. Eur Respir J 11, 8739.
  • Malats, N., Casals, T., Porta, M., Guarner, L., Estivill, X. & Real, F. X. 2001. Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group. Gut 48, 704.
  • Mateu, E. C. F., Ramos, M. D., Casals, T. & Bertranpetit, J. 2002. Can a place of origin of the main cystic fibrosis mutations be identified? Am J Hum Genet 70, 25764.
  • Niksic, M., Romano, M., Buratti, E., Pagani, F. & Baralle, F. E. 1999. Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9 [In Process Citation]. Hum Mol Genet 8, 233949.
  • Ockenga, J., Stuhrmann, M., Ballmann, M., Teich, N., Keim, V., Dork, T. & Manns, M. P. 2000. Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis. Am J Gastroenterol 95, 20617.
    Direct Link:
  • Onay, T., Topaloglu, O., Zielenski, J., Gokgoz, N., Kayserili, H., Camcioglu, Y., Cokugras, H., Akcakaya, N., Apak, M., Tsui, L. C. & Kirdar, B. 1998. Analysis of the CFTR gene in Turkish cystic fibrosis patients: identification of three novel mutations (3172delAC, P1013L and M1028I). Hum Genet 102, 22430.
  • Pagani, F., Buratti, E., Stuani, C., Romano, M., Zuccato, E., Niksic, M., Giglio, L., Faraguna, D. & Baralle, F. E. 2000. Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element. J Biol Chem 275, 210417.
  • Pier, G. B., Grout, M., Zaidi, T., Meluleni, G., Mueschenborn, S. S., Banting, G., Ratcliff, R., Evans, M. J. & Colledge, W. H. 1998. Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature 393, 7982.
  • Pignatti, P. F., Bombieri, C., Benetazzo, M., Casartelli, A., Trabetti, E., Gile, L. S., Martinati, L. C., Boner, A. L. & Luisetti, M. 1996. CFTR gene variant IVS8–5T in disseminated bronchiectasis. Am J Hum Genet 58, 889892.
  • Popa, I., Pop, L., Popa, Z., Schwarz, M. J., Hambleton, G., Malone, G. M., Haworth, A. & Super, M. 1997. Cystic fibrosis mutations in Romania. Eur J Pediatr 156, 2123.
  • Rave-Harel, N., Kerem, E., Nissim-Rafinia, M., Madjar, I., Goshen, R., Augarten, A., Rahat, A., Hurwitz, A., Darvasi, A. & Kerem, B. 1997. The molecular basis of partial penetrance of splicing mutations in cystic fibrosis. Am J Hum Genet 60, 8794.
  • Rich, D. P., Anderson, M. P., Gregory, R. J., Cheng, S. H., Paul, S., Jefferson, D. M., McCann, J. D., Klinger, K. W., Smith, A. E. & Welsh, M. J. 1990. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells [see comments]. Nature 347, 35863.
  • Riordan, J. R., Rommens, J. M., Kerem, B., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J. L. & et al 1989. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA [published erratum appears in Science 1989 Sep 29;245(4925):1437]. Science 245, 106673.
  • Romey, M. C., Guittard, C., Carles, S., Demaille, J., Claustres, M. & Ramsay, M. 1999. First putative sequence alterations in the minimal CFTR promoter region [letter]. J Med Genet 36, 2634.
  • Romey, M. C., Pallares-Ruiz, N., Mange, A., Mettling, C., Peytavi, R., Demaille, J. & Claustres, M. 2000. A naturally occurring sequence variation that creates a YY1 element is associated with increased cystic fibrosis transmembrane conductance regulator gene expression. J Biol Chem 275, 35617.
  • Rowntree, R. & Harris. A. 2002. DNA polymorphisms in potential regulatory elements of the CFTR gene alter transcription factor binding. Hum Genet 111, 6674.
  • Rozmahel, R., Wilschanski, M., Matin, A., Plyte, S., Oliver, M., Auerbach, W., Moore, A., Forstner, J., Durie, P., Nadeau, J., Bear, C. & Tsui, L. C. 1996. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet 12, 2807.
  • Salvatore, F., Scudiero, O. & Castaldo, G. 2002. Genotype-phenotype correlation in cystic fibrosis: The role of modifier genes. Am J Med Genet 111, 8895.
  • Schwiebert, E. M., Benos, D. J., Egan, M. E., Stutts, M. J. & Guggino, W. B. 1999. CFTR is a conductance regulator as well as a chloride channel. Physiol Rev 79, S14566.
  • Sharer, N., Schwarz, M., Malone, G., Howarth, A., Painter, J., Super, M. & Braganza, J. 1998. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 339, 64552.
  • Sheppard, D. N., Rich, D. P., Ostedgaard, L. S., Gregory, R. J., Smith, A. E. & Welsh, M. J. 1993. Mutations in CFTR associated with mild-disease-form Cl- channels with altered pore properties. Nature 362, 1604.
  • Shoshani, T., Augarten, A., Gazit, E., Bashan, N., Yahav, Y., Rivlin, Y., Tal, A., Seret, H., Yaar, L., Kerem, E. & et al. 1992. Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease. Am J Hum Genet 50, 2228.
  • Sobczyqska-Tomaszeska, A., Sands, D., Nowakowska, A. & Bal, J. 2002. The 1237G-A enhancer polymorphism of alpha-1 antitrypsin gene as modifier of pulmonary disease in cystic fibrosis patients. Journal of Cystic Fibrosis 1, S8687.
  • Teng, H., Jorissen, M., Van Poppel, H., Legius, E., Cassiman, J. J. & Cuppens, H. 1997. Increased proportion of exon 9 alternatively spliced CFTR transcripts in vas deferens compared with nasal epithelial cells. Hum Mol Genet 6, 8590.
  • Tsui, L. C. 1992. The spectrum of cystic fibrosis mutations. Trends Genet 8, 3928.
  • Tzetis, M., Efthymiadou, A., Doudounakis, S. & Kanavakis, E. 2001. Qualitative and quantitative analysis of mRNA associated with four putative splicing mutations (621+3A [RIGHTWARDS ARROW] G, 2751+2T [RIGHTWARDS ARROW] A, 296+1G [RIGHTWARDS ARROW] C, 1717–9T [RIGHTWARDS ARROW] C-D565G) and one nonsense mutation (E822X) in the CFTR gene. Hum Genet 109, 592601.
  • Vankeerberghen, A., Wei, L., Jaspers, M., Cassiman, J. J., Nilius, B. & Cuppens, H. 1998a. Characterization of 19 disease-associated missense mutations in the regulatory domain of the cystic fibrosis transmembrane conductance regulator. Hum Mol Genet 7, 17619.
  • Vankeerberghen, A., Wei, L., Teng, H., Jaspers, M., Cassiman, J. J., Nilius, B. & Cuppens, H. 1998b. Characterization of mutations located in exon 18 of the CFTR gene. FEBS Lett 437, 14.
  • Wang, X., Moylan, B., Leopold, D. A., Kim, J., Rubenstein, R. C., Togias, A., Proud, D., Zeitlin, P. L. & Cutting, G. R. 2000. Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. Jama 284, 18149.
  • Welsh, M., Ramsey, B. W., Accurso, F. & Cutting, G. R. 2001. Cystic Fibrosis. In The Molecular and Metabolic Basis of Inherited Disease (ed. A. B.CL Scriver, W. S.Sly & D.Valle), pp. 51215188. McGraw-Hill, New York .
  • Zielenski, J. 2000. Genotype and phenotype in cystic fibrosis. Respiration 67, 11733.
  • Zielenski, J., Corey, M., Rozmahel, R., Markiewicz, D., Aznarez, I., Casals, T., Larriba, S., Mercier, B., Cutting, G. R., Krebsova, A., Macek, M. Jr, Langfelder-Schwind, E., Marshall, B. C., DeCelie-Germana, J., Claustres, M., Palacio, A., Bal, J., Nowakowska, A., Ferec, C., Estivill, X., Durie, P. & Tsui, L. C. 1999. Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13 [letter]. Nat Genet 22, 1289.
  • Zielenski, J., Patrizio, P., Corey, M., Handelin, B., Markiewicz, D., Asch, R. & Tsui, L. C. 1995. CFTR gene variant for patients with congenital absence of vas deferens. Am J Hum Genet 57, 95860.
  • Zielenski, J., Rozmahel, R., Bozon, D., Kerem, B., Grzelczak, Z., Riordan, J. R., Rommens, J. & Tsui, L. C. 1991. Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics 10, 21428.
  • Zielenski, J. & Tsui, L. C. 1995. Cystic fibrosis: genotypic and phenotypic variations. Annu Rev Genet 29, 777807.